Ash Jayagopal
About Ash Jayagopal
Ash Jayagopal: Chief Scientific and Development Officer
Ash Jayagopal holds the position of Chief Scientific and Development Officer. In this role, Jayagopal oversees scientific research and development activities. With an extensive background in biomedical engineering and business, he contributes to the organization's strategic planning and growth. Previously, Jayagopal served as the Chief Scientific Officer at Opus Genetics, adding significant value with his scientific leadership.
Education and Expertise of Ash Jayagopal
Ash Jayagopal earned a Ph.D. in Biomedical Engineering from Vanderbilt University. He also holds an M.B.A. from the Kelley School of Business at Indiana University. These academic credentials have equipped Jayagopal with a robust understanding of both scientific and business domains, making him adept at leading multidisciplinary teams and managing complex projects in the field of biomedical engineering and pharmacology.
Ash Jayagopal's Professional Background
Ash Jayagopal has a comprehensive background in the field of molecular pharmacology and ophthalmology. Prior to his current role, he was the Executive Director of Discovery Medicine at Kodiak Sciences. He also held the position of Head of Molecular Pharmacology and Biomarkers in Ophthalmology at Roche. In these roles, Jayagopal was responsible for leading research programs and advancing scientific discoveries in the field of ophthalmology.
Achievements of Ash Jayagopal
Ash Jayagopal has authored over 40 peer-reviewed publications, contributing valuable knowledge to the scientific community. He has received multiple awards, including the Roche Key Contributor Award, Dolly Green Special Scholar Award from Research to Prevent Blindness, and a Junior Faculty Award from the American Diabetes Association. Jayagopal is a Fellow of the Association for Research in Vision and Ophthalmology (ARVO). He also serves as the President of the Association for Ocular Pharmacology and Therapeutics (AOPT) and is a member of the Innovation Advisory Council for Foundation Fighting Blindness.
Ash Jayagopal's Editorial and Advisory Roles
Ash Jayagopal is actively involved in several professional organizations and advisory councils. He currently sits on the Editorial Board of the Journal of Ocular Pharmacology and Therapeutics, where he contributes to the review and dissemination of research in the field. Jayagopal is also a member of the Innovation Advisory Council for Foundation Fighting Blindness, where he provides strategic guidance on innovation in vision research.